Latest / Artificial Intelligence Exposed / How AI Ends the Average Patient

Transcript

How AI Ends the Average Patient · Artificial Intelligence Exposed

• 0:00
  Speaker 1: What if I told you the medication sitting in your
• 0:01
  Speaker 1: cabinet right now was designed for a ghost?
• 0:06
  Speaker 2: A ghost. That's a pretty intense way to put it.
• 0:10
  Speaker 1: Well, it's true, right? I mean, it was designed, tested
• 0:13
  Speaker 1: and optimized for this statistical average human being that from
• 0:16
  Speaker 1: a biological standpoint doesn't actually exist.
• 0:18
  Speaker 2: Yeah, that's entirely accurate. Right. The average patient is a myth. Right.
• 0:23
  Speaker 1: So I want you, the listener, to imagine walking into
• 0:25
  Speaker 1: a clinic where the physician doesn't even glance at standard
• 0:29
  Speaker 1: treatment guidelines.
• 0:29
  Speaker 2: Like at all. Which sounds terrifying, but it's actually the goal.
• 0:34
  Speaker 1: Exactly. Because instead, before a prescription pad is ever even touched,
• 0:38
  Speaker 1: a computational model has already run a simulation. It's looking
• 0:42
  Speaker 1: at how your specific biological ecosystem down to, you know,
• 0:45
  Speaker 1: your individual enzyme levels will metabolize a certain chemical compound.
• 0:50
  Speaker 2: We're not waiting around for side effects to manifest anymore.
• 0:53
  Speaker 1: Right. We are predicting biochemical interactions before a drug even
• 0:57
  Speaker 1: enters your bloodstream. And that is the mission of this
• 1:00
  Speaker 1: deep dive.
• 1:01
  Speaker 2: It's a massive paradigm shift.
• 1:02
  Speaker 1: It really is. We are exploring the shift away from
• 1:05
  Speaker 1: standardized care and looking at how artificial intelligence is fundamentally
• 1:09
  Speaker 1: dismantling this whole concept of the average patient.
• 1:12
  Speaker 2: Treating you as a unique biological ecosystem.
• 1:15
  Speaker 1: Yeah. So we're going to dissect why standard treatments sometimes
• 1:19
  Speaker 1: just completely fail and how AI might soon tailor these
• 1:23
  Speaker 1: medical interventions to your exact biological profile. Okay, let's unpack this.
• 1:27
  Speaker 2: To really appreciate the scale of this shift, we have to,
• 1:32
  Speaker 2: we kind of have to look at the statistical foundation
• 1:34
  Speaker 2: of modern medicine.
• 1:35
  Speaker 1: Like the history of it.
• 1:36
  Speaker 2: Right. For the past century, medical progress has been completely
• 1:39
  Speaker 2: driven by standardizing things, you know, standard guidelines, standard antibiotics, vaccines.
• 1:46
  Speaker 1: And to be fair, that standardized approach has saved Countless lives.
• 1:49
  Speaker 1: We can't ignore that.
• 1:50
  Speaker 2: Oh, absolutely. It gave us the eradication of smallpox. But
• 1:54
  Speaker 2: the core mechanism there is optimizing for the mean. It's
• 1:58
  Speaker 2: all based on the randomized control trial.
• 2:00
  Speaker 1: Right, where you test a drug on a massive group.
• 2:02
  Speaker 2: Exactly. You take 10,000 people, you give them a compound,
• 2:06
  Speaker 2: and if the average benefit outweighs the average harm, boom,
• 2:09
  Speaker 2: you have a standardized treatment protocol.
• 2:11
  Speaker 1: But the word there is average.
• 2:13
  Speaker 2: Yeah.
• 2:13
  Speaker 1: Yeah.
• 2:14
  Speaker 2: And that statistical average hides a massive, just incredible amount
• 2:18
  Speaker 2: of biological variance.
• 2:19
  Speaker 1: Because biological differences mean that exact same treatment yields totally
• 2:23
  Speaker 1: different results depending on the person.
• 2:25
  Speaker 2: Precisely. In clinical pharmacology, we use this metric. It's called
• 2:30
  Speaker 2: the number needed to treat, or NNT.
• 2:33
  Speaker 1: NNT. Okay, what does that actually measure?
• 2:36
  Speaker 2: It tells you how many people need to take a
• 2:37
  Speaker 2: given drug for just one person to see a clinical benefit.
• 2:41
  Speaker 1: Wait, really? Just for one person?
• 2:43
  Speaker 2: Just for one. And for some of the most prescribed
• 2:46
  Speaker 2: drugs in the world, like statins for cholesterol, the NNT
• 2:51
  Speaker 2: can be in the dozens, sometimes even the hundreds, depending
• 2:54
  Speaker 2: on what specific outcome you're measuring.
• 2:56
  Speaker 1: So let me get this straight. You could have 50
• 2:59
  Speaker 1: people taking a drug every single day.
• 3:01
  Speaker 2: Experiencing the metabolic load, the potential side effects, the cost.
• 3:06
  Speaker 1: Right, all of that. Just to prevent a single cardiovascular
• 3:09
  Speaker 1: event in one person, while the other 49 get literally
• 3:14
  Speaker 1: zero direct benefit.
• 3:15
  Speaker 2: Exactly. That is the reality of standardized medicine. Patients with
• 3:19
  Speaker 2: the exact same symptoms might have entirely different underlying biology.
• 3:24
  Speaker 1: So patient A might metabolize a drug really fast, right?
• 3:27
  Speaker 2: Yeah, turning a standard dose into basically a placebo. It
• 3:30
  Speaker 2: clears out before it does anything.
• 3:31
  Speaker 1: And patient B?
• 3:33
  Speaker 2: Patient B might lack a specific transport protein, so the
• 3:37
  Speaker 2: drug just accumulates to toxic levels in their blood.
• 3:40
  Speaker 1: Man. So it's kind of like buying a suit. Standardized
• 3:44
  Speaker 1: medicine is like buying an off-the-rack suit. It's highly efficient.
• 3:48
  Speaker 1: They stamp out millions of them. And it mostly covers you.
• 3:52
  Speaker 2: Right. But it doesn't fit anyone perfectly.
• 3:54
  Speaker 1: Exactly. Whereas personalized medicine is like having a master tailor
• 3:57
  Speaker 1: cut a suit to your exact hyper-specific measurements.
• 4:01
  Speaker 2: That's a great analogy. And the AI is essentially the
• 4:04
  Speaker 2: master tailor here. But instead of measuring your inseam, it's
• 4:08
  Speaker 2: processing millions of genetic variations and thousands of biological measurements simultaneously.
• 4:13
  Speaker 1: Which a human doctor just physically cannot do.
• 4:16
  Speaker 2: It's impossible. Human cognition just doesn't have the bandwidth to
• 4:18
  Speaker 2: process tens of thousands of variables at once. But I
• 4:23
  Speaker 2: want to emphasize why this matters on a macro scale.
• 4:26
  Speaker 1: Go for it.
• 4:27
  Speaker 2: Having more data doesn't automatically mean we have better medicine.
• 4:31
  Speaker 2: The information the AI uses, it has to be relevant, accurate,
• 4:35
  Speaker 2: and clinically validated.
• 4:36
  Speaker 1: Right. Otherwise, it's just noise.
• 4:38
  Speaker 2: Exactly. Just throwing petabytes of data at a neural network
• 4:41
  Speaker 2: doesn't cure a patient.
• 4:43
  Speaker 1: So to understand how we tailor this metaphorical suit, we
• 4:46
  Speaker 1: have to look at the fabric itself, which is human DNA.
• 4:49
  Speaker 2: The foundational code.
• 4:50
  Speaker 1: Right. And the human genome contains, what, billions of DNA
• 4:53
  Speaker 1: building blocks?
• 4:54
  Speaker 2: Billions, yeah. Historically, we looked at genetics in a very
• 4:58
  Speaker 2: binary way.
• 4:59
  Speaker 1: Like finding a single broken gene.
• 5:01
  Speaker 2: Right. Mendelian genetics. You test for, say, a BRCA1 mutation.
• 5:07
  Speaker 2: If you have it, your risk for breast cancer is massive.
• 5:10
  Speaker 2: It's a single variant with a huge effect.
• 5:12
  Speaker 1: But most diseases aren't like that, are they?
• 5:15
  Speaker 2: Not at all. The vast majority of common diseases, type
• 5:19
  Speaker 2: 2 diabetes, cardiovascular disease, psychiatric disorders like schizophrenia.
• 5:25
  Speaker 1: They're way more complicated.
• 5:26
  Speaker 2: Extremely. They are what we call polygenic. They involve complex
• 5:31
  Speaker 2: combinations of thousands of different genes, plus your environment, plus lifestyle.
• 5:36
  Speaker 1: So how on earth do you calculate risk for that?
• 5:38
  Speaker 1: If it's thousands of tiny variations, a human can't just
• 5:41
  Speaker 1: eyeball a lab report and say, oh, yeah, you're at risk.
• 5:44
  Speaker 2: They can't. And that's where AI is driving the explosion
• 5:47
  Speaker 2: of genomics. It helps researchers build something called polygenic risk scores.
• 5:52
  Speaker 1: Polygenic risk scores.
• 5:55
  Speaker 2: Yeah. The AI combines information from millions of tiny genetic variants,
• 5:59
  Speaker 2: those single building block changes, to estimate your predisposition to
• 6:03
  Speaker 2: a specific condition.
• 6:04
  Speaker 1: It aggregates them all together. Right.
• 6:07
  Speaker 2: It assigns a statistical weight to every tiny mutation and
• 6:10
  Speaker 2: outputs a continuous risk score.
• 6:13
  Speaker 1: Okay, I have to push back here, though.
• 6:15
  Speaker 2: Sure.
• 6:15
  Speaker 1: Because if a patient gets a report from their doctor
• 6:18
  Speaker 1: and it says they have a sky-high polygenic risk score
• 6:21
  Speaker 1: for heart disease, aren't they just essentially doomed by their DNA? Like,
• 6:26
  Speaker 1: that feels incredibly fatalistic.
• 6:29
  Speaker 2: That is the major danger in how this is communicated
• 6:32
  Speaker 2: because predisposition is not destiny. Not even close.
• 6:36
  Speaker 1: Okay, so you can have high risk and never get sick.
• 6:39
  Speaker 2: Absolutely. The DNA is just the architectural blueprint of the building.
• 6:43
  Speaker 2: But your environment, your lifestyle, what you eat, whether you smoke,
• 6:47
  Speaker 2: that acts as the weather.
• 6:49
  Speaker 1: Ah, I see.
• 6:50
  Speaker 2: A poorly constructed building might stand forever in perfect weather.
• 6:54
  Speaker 2: And a beautifully engineered building can still collapse in a hurricane.
• 6:58
  Speaker 1: So the genes have to actually be triggered by the environment.
• 7:01
  Speaker 2: Exactly. But there's a massive caveat here regarding these AI models.
• 7:06
  Speaker 2: And we have to talk about model diversity.
• 7:08
  Speaker 1: Right. The bias in the training data.
• 7:10
  Speaker 2: It is a critical flaw. If AI models are trained
• 7:13
  Speaker 2: predominantly on one ancestry group, historically European populations, they will
• 7:19
  Speaker 2: completely fail other populations.
• 7:21
  Speaker 1: Because the genetic markers are different?
• 7:23
  Speaker 2: Yes. A specific genetic variant might perfectly predict a disease
• 7:28
  Speaker 2: in a European cohort. But in an African or East
• 7:31
  Speaker 2: Asian cohort, due to different evolutionary histories, that same variant
• 7:36
  Speaker 2: might mean absolutely nothing.
• 7:38
  Speaker 1: Oh, wow. So if the model isn't diverse, it's confidently
• 7:42
  Speaker 1: giving out wrong risk scores.
• 7:44
  Speaker 2: Confidently wrong, which unintentionally worsens existing healthcare inequalities.
• 7:49
  Speaker 1: That's a huge problem. So, okay, genomics gives us the
• 7:52
  Speaker 1: space lane risk, right, the blueprints. But how is this
• 7:55
  Speaker 1: individualized approach actually being used right now to fight active,
• 7:59
  Speaker 1: severe diseases?
• 8:01
  Speaker 2: The clearest example, the absolute vanguard of personalized medicine today
• 8:04
  Speaker 2: is oncology. cancer treatment.
• 8:07
  Speaker 1: It really feels like we are completely redefining what a
• 8:09
  Speaker 1: cancer diagnosis even means.
• 8:11
  Speaker 2: We are. The entire taxonomy has changed. Historically, cancers were
• 8:16
  Speaker 2: classified just by the organ. You had lung cancer, breast cancer,
• 8:20
  Speaker 2: colon cancer.
• 8:20
  Speaker 1: The geography of it.
• 8:22
  Speaker 2: Right. And the geography dictated the treatment. But now we
• 8:26
  Speaker 2: realize that two lung cancers sitting in the exact same
• 8:28
  Speaker 2: part of the lung might operate completely differently at a
• 8:31
  Speaker 2: biological level.
• 8:33
  Speaker 1: Here's where it gets really interesting. It's like judging a
• 8:37
  Speaker 1: book not by its cover, which is the organ it's in,
• 8:40
  Speaker 1: but by the actual words printed on the page.
• 8:43
  Speaker 2: The molecular code.
• 8:44
  Speaker 1: Exactly. Two books with the same cover could have a
• 8:46
  Speaker 1: totally different story inside. So if we just classify cancer
• 8:50
  Speaker 1: by the organ, we are ignoring the underlying molecular subgroup.
• 8:54
  Speaker 2: And ignoring that code is why older chemotherapies had such
• 8:57
  Speaker 2: high failure rates. We need to know the specific mutation
• 9:00
  Speaker 2: driving the tumor, so we can use a targeted therapy
• 9:03
  Speaker 2: that shuts down that exact pathway.
• 9:05
  Speaker 1: And finding that pathway involves looking at the tissue, right?
• 9:08
  Speaker 1: Which brings us to digital pathology, because AI is doing
• 9:11
  Speaker 1: things with biopsies that blow my mind.
• 9:14
  Speaker 2: Oh, digital pathology is incredible. So traditionally, a human pathologist
• 9:18
  Speaker 2: looks at a stained tissue slide under a microscope.
• 9:21
  Speaker 1: Which is super skilled work.
• 9:22
  Speaker 2: Highly skilled. But it's visual. And human eyes get tired.
• 9:26
  Speaker 2: Digital pathology involves using these massive scanners to convert those
• 9:30
  Speaker 2: glass tissue slides into high-resolution digital images.
• 9:33
  Speaker 1: How big are we talking?
• 9:35
  Speaker 2: Billions of pixels per slide. Gigabytes of data for a
• 9:38
  Speaker 2: single tissue sample. And then we deploy AI, specifically convolutional
• 9:43
  Speaker 2: neural networks, to analyze that image.
• 9:47
  Speaker 1: And what's fascinating here is that the AI isn't just
• 9:49
  Speaker 1: taking over the doctor's job, right? It's not replacing the pathologist.
• 9:52
  Speaker 2: Not at all. It acts as an insanely powerful assistant.
• 9:57
  Speaker 2: It helps them count cells, locate suspicious regions, and it
• 10:00
  Speaker 2: highlights subtle microscopic features that the human eye simply cannot quantify.
• 10:05
  Speaker 1: Like the exact texture of the cells?
• 10:08
  Speaker 2: Right. The spatial distribution of immune cells around a tumor.
• 10:12
  Speaker 2: AI can look at that geometry and actually predict if
• 10:14
  Speaker 2: a tumor is likely to spread.
• 10:16
  Speaker 1: But wait, If an AI looks at an image and
• 10:18
  Speaker 1: predicts a specific molecular feature, a doctor isn't just going
• 10:21
  Speaker 1: to prescribe a heavy chemo drug based on an image scan,
• 10:24
  Speaker 1: are they?
• 10:24
  Speaker 2: No, absolutely not. And that's a crucial point. Any AI
• 10:28
  Speaker 2: prediction about a molecular feature has to be rigorously backed
• 10:32
  Speaker 2: by clinical evidence.
• 10:33
  Speaker 1: It has to be verified in a lab.
• 10:35
  Speaker 2: Yes. Molecular sequencing is still required. But the AI is
• 10:40
  Speaker 2: the ultimate triage tool. It instantly flags which patients need
• 10:44
  Speaker 2: that expensive testing immediately.
• 10:46
  Speaker 1: Okay, so knowing the exact molecular nature of the disease
• 10:50
  Speaker 1: is half the battle, but the other half is making
• 10:52
  Speaker 1: sure the drug you use to fight it actually works
• 10:54
  Speaker 1: in your specific body.
• 10:56
  Speaker 2: Which is where pharmacogenomics comes in.
• 10:59
  Speaker 1: Pharmacogenomics. That's a mouthful. Getting the right drug at the
• 11:03
  Speaker 1: right dose.
• 11:04
  Speaker 2: Exactly. It's the study of how your genetic differences affect
• 11:07
  Speaker 2: drug absorption and metabolism.
• 11:09
  Speaker 1: Mostly happening in the liver, right?
• 11:11
  Speaker 2: Primarily the liver, yes. You have these specific enzyme pathways,
• 11:16
  Speaker 2: and depending on your genetics, you might be an ultra-rapid
• 11:18
  Speaker 2: metabolizer or a poor metabolizer.
• 11:21
  Speaker 1: Let's break that down. If you lack a certain enzyme,
• 11:25
  Speaker 1: what happens to a standard dose of medication?
• 11:28
  Speaker 2: If you're a poor metabolizer, the drug stays in your
• 11:31
  Speaker 2: body way too long. It isn't cleared out.
• 11:33
  Speaker 1: So it just builds up.
• 11:34
  Speaker 2: It builds up exponentially, which massively increases your risk of
• 11:38
  Speaker 2: severe toxic side effects.
• 11:40
  Speaker 1: And on the flip side?
• 11:42
  Speaker 2: If you're an ultra rapid metabolizer, the drug moves through
• 11:45
  Speaker 2: your system so fast it never has a chance to work.
• 11:47
  Speaker 2: It's rendered totally ineffective.
• 11:49
  Speaker 1: So what does this all mean when someone is taking
• 11:52
  Speaker 1: like five different medications? Because that's super common, especially in
• 11:56
  Speaker 1: older patients. Polypharmacy.
• 11:58
  Speaker 2: Polypharmacy is incredibly complex. You have patients on blood pressure meds,
• 12:04
  Speaker 2: cholesterol meds, antidepressants all at once.
• 12:07
  Speaker 1: That's like a complex chemical traffic jam in the liver.
• 12:10
  Speaker 2: It really is. Drug A might block the enzyme needed
• 12:13
  Speaker 2: to clear drug B, while your genetics mean you already
• 12:17
  Speaker 2: process drug C too slowly. A human doctor cannot manually
• 12:21
  Speaker 2: calculate all those interactions in their head.
• 12:23
  Speaker 1: So the AI acts as the ultimate traffic controller.
• 12:27
  Speaker 2: Precisely. It analyzes your genomics, your records, and lab results
• 12:32
  Speaker 2: to discover new drug-gene relationships. It predicts those complex interactions
• 12:36
  Speaker 2: to prevent adverse events.
• 12:38
  Speaker 1: But there have to be severe safety requirements here, right?
• 12:41
  Speaker 1: Because if an automated prescribing system makes a mistake, that's
• 12:44
  Speaker 1: immediate direct harm to the patient.
• 12:47
  Speaker 2: The safety ceiling is absolute. An AI cannot just rely
• 12:51
  Speaker 2: on a plausible sounding explanation to change a dose. It
• 12:54
  Speaker 2: has to be anchored in rigorous FDA approved clinical guidelines.
• 12:58
  Speaker 2: The AI is there to support the medical professional, not
• 13:02
  Speaker 2: to replace clinical judgment.
• 13:03
  Speaker 1: Right. It highlights the danger, but the doctor makes the call.
• 13:06
  Speaker 2: Exactly.
• 13:07
  Speaker 1: Okay, so medication reactions are just one piece of a
• 13:10
  Speaker 1: patient's massive medical history. But where does all that history
• 13:13
  Speaker 1: actually live?
• 13:15
  Speaker 2: It is mostly buried in electronic health records.
• 13:18
  Speaker 1: The EHRs.
• 13:19
  Speaker 2: Which, from what I understand, are basically massive fragmented data dumps.
• 13:24
  Speaker 1: They are.
• 13:25
  Speaker 2: Hospitals hold an unbelievable amount of data. But it's a mess.
• 13:30
  Speaker 2: You have structured data, like lab numbers, but the most
• 13:33
  Speaker 2: important context is unstructured.
• 13:35
  Speaker 1: You mean like the doctor's type notes? Right.
• 13:38
  Speaker 2: Clinical notes, discharge summaries, imaging reports. It's all text.
• 13:43
  Speaker 1: So how does AI even read that?
• 13:45
  Speaker 2: We use natural language processing, or NLP. Specifically, transformer models,
• 13:51
  Speaker 2: which are incredible at extracting insights from messy, unstructured text.
• 13:55
  Speaker 2: They understand medical jargon, abbreviations, context.
• 13:59
  Speaker 1: And once the AI parses all those notes, it builds
• 14:01
  Speaker 1: a timeline, right? Which leads to predictive medicine? Yes.
• 14:05
  Speaker 2: Predictive medicine is about spotting clinical deterioration before it's visually
• 14:09
  Speaker 2: obvious to the nursing staff.
• 14:10
  Speaker 1: Spotting it early. Right.
• 14:12
  Speaker 2: The AI analyzes the trajectory of your vitals and labs.
• 14:15
  Speaker 2: And it can send early warnings for severe conditions like
• 14:18
  Speaker 2: sepsis or acute kidney injury. It detects the hidden patterns
• 14:22
  Speaker 2: hours before the patient crashes.
• 14:25
  Speaker 1: But I have to point out the human element here.
• 14:27
  Speaker 1: Because if an AI is constantly beeping and sending alerts
• 14:30
  Speaker 1: on a hospital floor... basically crying wolf, won't doctors just
• 14:34
  Speaker 1: get totally annoyed and start ignoring it?
• 14:36
  Speaker 2: This raises an extremely important question. It's a phenomenon called
• 14:40
  Speaker 2: alert fatigue.
• 14:41
  Speaker 1: Alert fatigue. Yeah.
• 14:43
  Speaker 2: If the algorithm is too sensitive and flags every minor fluctuation,
• 14:47
  Speaker 2: the staff will literally turn the monitor off. A useful
• 14:50
  Speaker 2: AI needs statistical accuracy, yes, but it also requires appropriate thresholds.
• 14:56
  Speaker 1: It has to explain why it's beeping.
• 14:58
  Speaker 2: Exactly. Clear explanations. It needs to say, I am alerting
• 15:02
  Speaker 2: you to sepsis risk specifically because the lactate is rising
• 15:06
  Speaker 2: while the blood pressure is dropping. Seamless workflow integration is
• 15:09
  Speaker 2: required so it doesn't overwhelm the staff.
• 15:12
  Speaker 1: Makes total sense. Now, EHRs track you when you're interacting
• 15:16
  Speaker 1: with the hospital, but that's what, maybe 1% of your life?
• 15:20
  Speaker 2: For most people, far less than that.
• 15:22
  Speaker 1: So what about the other 99%? That's where wearables come in.
• 15:26
  Speaker 2: Continuous telemetry.
• 15:27
  Speaker 1: Yes.
• 15:28
  Speaker 2: Smartwatches, fitness trackers. Connected blood pressure monitors.
• 15:32
  Speaker 1: And continuous glucose monitors, the CGMs.
• 15:35
  Speaker 2: Right. Traditional medicine relies on isolated snapshots. You go to
• 15:38
  Speaker 2: the clinic on a Tuesday, they take your blood pressure once.
• 15:42
  Speaker 1: It's like looking at a single Polaroid photograph of your health.
• 15:45
  Speaker 2: Good analogy. And that snapshot could be skewed because you
• 15:48
  Speaker 2: drank coffee or you're stressed about being at the doctor.
• 15:52
  Speaker 1: White coat syndrome.
• 15:53
  Speaker 2: Exactly. But continuous monitoring from wearables reveals the actual trends.
• 15:58
  Speaker 2: It's watching a 24-7 documentary film of your physiology. We
• 16:02
  Speaker 2: can see how your heart rate varies by sleep architecture,
• 16:05
  Speaker 2: by stress, by subclinical illness.
• 16:08
  Speaker 1: And when you connect that continuous data stream to an
• 16:10
  Speaker 1: actual intervention, you get a closed-loop system, which is basically
• 16:15
  Speaker 1: science fiction coming to life.
• 16:17
  Speaker 2: Closed-loop systems are the pinnacle of this. Automated insulin delivery
• 16:21
  Speaker 2: is the best example right now.
• 16:23
  Speaker 1: How does that work in practice?
• 16:25
  Speaker 2: You have a CGM sensor. continuously measuring the patient's glucose levels.
• 16:29
  Speaker 2: That real-time data feeds into an algorithm on a smartphone
• 16:32
  Speaker 2: or a pump.
• 16:33
  Speaker 1: And the algorithm acts like a brain.
• 16:35
  Speaker 2: Right. It calculates the exact insulin requirement and signals the
• 16:39
  Speaker 2: attached pump to deliver the hormone continuously, adjusting dynamically as
• 16:43
  Speaker 2: the patient eats or exercises.
• 16:46
  Speaker 1: It completely removes the burden from the patient.
• 16:49
  Speaker 2: It transforms chronic disease management. Instead of rigid follow-up schedules
• 16:53
  Speaker 2: every three months, We manage care based on real-time data stability.
• 16:57
  Speaker 2: Appointments can be adjusted dynamically based on your actual individualized risk.
• 17:02
  Speaker 1: Okay, so let's pull all of these threads together. We
• 17:04
  Speaker 1: have the DNA blueprints. We have digital pathology images. We
• 17:08
  Speaker 1: have the unstructured EHR notes. And we have this 24-7
• 17:11
  Speaker 1: wearable data. What actually happens when we combine all these
• 17:15
  Speaker 1: completely different languages of the body?
• 17:18
  Speaker 2: When you combine them, you enter the realm of multi-omics.
• 17:21
  Speaker 1: Multi-omics, breaking down the layers of biology.
• 17:24
  Speaker 2: Right. Genomics is the DNA layer. Transcriptomics is the RNA layer.
• 17:29
  Speaker 2: Proteomics is the proteins. Metabolomics is the metabolites. And microbiomics
• 17:34
  Speaker 2: is the microbes in your gut.
• 17:36
  Speaker 1: Wow.
• 17:36
  Speaker 2: When AI combines all of these, plus radiomics, which is
• 17:40
  Speaker 2: extracting hidden sub-visual textures from MRI and CT scans, we
• 17:44
  Speaker 2: approach the ultimate ambition of this field.
• 17:47
  Speaker 1: Which is the medical digital twin.
• 17:49
  Speaker 2: The digital twin, yes.
• 17:50
  Speaker 1: Okay, explain what that actually is.
• 17:52
  Speaker 2: It's a computational representation of your personal physiology. Imagine simulating
• 17:57
  Speaker 2: your heart's specific blood flow in a computer so a
• 18:00
  Speaker 2: surgeon can test different stent placements virtually.
• 18:03
  Speaker 1: Testing it on the computer before ever touching your actual body.
• 18:06
  Speaker 2: Exactly.
• 18:07
  Speaker 1: I got to be honest, though. Can we really build
• 18:09
  Speaker 1: a complete Sims-style digital replica of a human being? That
• 18:13
  Speaker 1: feels a bit overhyped.
• 18:15
  Speaker 2: It is overhyped if you think we are simulating the
• 18:17
  Speaker 2: entire body at once. Human biology is far too complex
• 18:21
  Speaker 2: for a complete bodily replica right now.
• 18:23
  Speaker 1: So what are we actually building?
• 18:25
  Speaker 2: Targeted digital twins, specifically for single organs or isolated metabolic processes.
• 18:32
  Speaker 2: A digital twin of your heart or your pancreas. Those
• 18:35
  Speaker 2: are becoming incredibly viable.
• 18:37
  Speaker 1: But there are risks, obviously.
• 18:39
  Speaker 2: Massive risks. The primary danger is overfitting. If an AI
• 18:43
  Speaker 2: model is overfit to a specific hospital's data... It might
• 18:47
  Speaker 2: mistake a local correlation for actual biological causation. If the
• 18:51
  Speaker 2: simulation is wrong, the surgical intervention is wrong.
• 18:54
  Speaker 1: That's terrifying. But this hypergranular level of detail, it isn't
• 18:59
  Speaker 1: just for common diseases or surgeries, right? It's literally a
• 19:02
  Speaker 1: lifeline for the hardest-to-solve medical mysteries.
• 19:04
  Speaker 2: Yes. Rare diseases.
• 19:06
  Speaker 1: These are the diagnostic odysseys we hear about where patients
• 19:09
  Speaker 1: spend years undergoing painful testing just to get a name
• 19:12
  Speaker 1: for what's wrong with them.
• 19:13
  Speaker 2: Because a rare disease might only affect a few hundred
• 19:15
  Speaker 2: people globally. A standard doctor might never see a case
• 19:18
  Speaker 2: in their entire career.
• 19:20
  Speaker 1: So how does AI solve that?
• 19:22
  Speaker 2: It can ingest a patient's entire history, every symptom, every
• 19:25
  Speaker 2: lab test, all their genetic variants. And then it scans
• 19:29
  Speaker 2: millions of global case reports and medical literature in seconds.
• 19:32
  Speaker 1: It's basically finding the needle in a haystack.
• 19:35
  Speaker 2: Exactly.
• 19:36
  Speaker 1: But the AI gives the doctor a giant, hyper-tuned electromagnet.
• 19:39
  Speaker 2: That's a perfect way to put it. It suggests overlooked
• 19:43
  Speaker 2: conditions that a human would easily miss. And we are
• 19:46
  Speaker 2: seeing similar breakthroughs in immunotherapy for cancer and autoimmune disorders.
• 19:51
  Speaker 1: Immunotherapy uses your own body's immune system to fight the disease, right? Right.
• 19:56
  Speaker 2: But it doesn't work for everyone. So AI uses this
• 19:59
  Speaker 2: technique called single cell sequencing.
• 20:01
  Speaker 1: Single cell.
• 20:02
  Speaker 2: Yeah. It literally examines the biological differences among individual cells
• 20:07
  Speaker 2: within a tumor. It maps the cellular battlefield to figure
• 20:11
  Speaker 2: out exactly why some tumors resist treatment while others shrink.
• 20:15
  Speaker 1: It's incredible.
• 20:16
  Speaker 2: It is. But I have to caution that while finding
• 20:20
  Speaker 2: these precise disease subtypes is amazing, translating those molecular discoveries
• 20:25
  Speaker 2: into routine care takes years.
• 20:28
  Speaker 1: Because you have to prove it actually helps the patient.
• 20:30
  Speaker 2: Yes. Years of clinical validation are required to ensure actual
• 20:33
  Speaker 2: patient benefit. Right.
• 20:35
  Speaker 1: And while the science sounds miraculous... Miracles in health care
• 20:39
  Speaker 1: usually come with a hefty price tag and a ton
• 20:41
  Speaker 1: of red tape.
• 20:42
  Speaker 2: The economics are a massive hurdle.
• 20:43
  Speaker 1: Let's talk about that, because gathering all this data, the sequencing,
• 20:47
  Speaker 1: the advanced imaging, developing targeted therapies, it is incredibly expensive.
• 20:52
  Speaker 2: Prohibitively expensive for many.
• 20:54
  Speaker 1: And if only wealthy patients at elite research hospitals get
• 20:57
  Speaker 1: access to personalized medicine, health inequalities will widen drastically.
• 21:01
  Speaker 2: It's going to create a two-tiered health system.
• 21:04
  Speaker 1: And beyond access, there's the privacy issue. Data privacy here
• 21:08
  Speaker 1: is absolutely paramount.
• 21:09
  Speaker 2: More than anything else. Unlike a compromised password, you cannot
• 21:12
  Speaker 2: change your DNA. If your genomic data is leaked, it's
• 21:16
  Speaker 2: out there forever.
• 21:17
  Speaker 1: So how do we train these massive AI models on
• 21:20
  Speaker 1: patient data without violating privacy?
• 21:22
  Speaker 2: The tech industry is developing solutions like federated learning.
• 21:26
  Speaker 1: Federated learning. How does that work?
• 21:28
  Speaker 2: Instead of moving all the sensitive patient data from different
• 21:30
  Speaker 2: hospitals into one central database, we send the AI model
• 21:34
  Speaker 2: to the hospitals. The model trains on the local data
• 21:37
  Speaker 2: behind the hospital's strict firewall.
• 21:39
  Speaker 1: Oh, I see.
• 21:40
  Speaker 2: And then only the mathematical upgrades, what the model learned,
• 21:44
  Speaker 2: are sent back to the central server. The actual patient
• 21:47
  Speaker 2: data never moves.
• 21:48
  Speaker 1: That's incredibly smart. I've also heard about using synthetic medical data.
• 21:53
  Speaker 2: Generative artificial records, yeah. AI can generate fake patient data
• 21:58
  Speaker 2: that perfectly mimics the statistical complexities of real diseases, but
• 22:04
  Speaker 2: it doesn't belong to any real human.
• 22:06
  Speaker 1: But wait, if an AI makes a biased recommendation based
• 22:09
  Speaker 1: on synthetic data, who is responsible? And is synthetic data
• 22:14
  Speaker 1: really a safe substitute for actual patient history?
• 22:17
  Speaker 2: It's a huge debate. Synthetic data can inadvertently preserve original
• 22:21
  Speaker 2: biases from the real data it was modeled on. Or
• 22:24
  Speaker 2: it might completely miss rare, nuanced conditions.
• 22:28
  Speaker 1: So the AI has to be able to explain itself.
• 22:31
  Speaker 2: Explainable AI is a major focus right now. Systems that
• 22:35
  Speaker 2: show their mathematical work. But a warning here. A convincing,
• 22:39
  Speaker 2: plausible explanation generated by an AI is not proof that
• 22:43
  Speaker 2: its medical recommendation is biologically correct.
• 22:47
  Speaker 1: Right, because AI can hallucinate. It can sound super confident
• 22:50
  Speaker 1: while being totally wrong.
• 22:52
  Speaker 2: Exactly. Clinical validation by a human expert is always, always required.
• 22:58
  Speaker 1: Which brings us to the patient experience. Because as patients,
• 23:02
  Speaker 1: how are we supposed to navigate this tidal wave of
• 23:04
  Speaker 1: complex data without completely losing our minds?
• 23:07
  Speaker 2: That is where large language models, LLMs, are stepping in.
• 23:11
  Speaker 1: Like the conversational AI interfaces?
• 23:13
  Speaker 2: Right. They can act as translators. They summarize massive treatment
• 23:16
  Speaker 2: histories and explain dense medical jargon in plain language, helping
• 23:20
  Speaker 2: both doctors and patients communicate better.
• 23:23
  Speaker 1: But personalized medicine has to respect patient preferences, too. Like,
• 23:26
  Speaker 1: you could have two patients with the exact same biological profile,
• 23:30
  Speaker 1: but they might choose totally different treatments based on their
• 23:33
  Speaker 1: personal values, right?
• 23:35
  Speaker 2: Absolutely. One patient might want aggressive treatment no matter what,
• 23:39
  Speaker 2: while another might prioritize minimizing side effects to maintain their
• 23:42
  Speaker 2: quality of life. The AI doesn't know your values.
• 23:46
  Speaker 1: Okay, let's unpack this, because I'm worried about extreme over-medicalization.
• 23:50
  Speaker 1: With all these sensors and genetic risk scores, aren't we
• 23:53
  Speaker 1: just going to turn into a society of hypochondriacs, tracking
• 23:56
  Speaker 1: every single harmless biological fluctuation?
• 23:59
  Speaker 2: If we connect this to the bigger picture, you're hitting
• 24:02
  Speaker 2: on one of the biggest risks of this entire movement.
• 24:05
  Speaker 2: I totally agree.
• 24:07
  Speaker 1: It's just too much information.
• 24:09
  Speaker 2: Good personalized medicine distinguishes meaningful risk from ordinary harmless variability.
• 24:14
  Speaker 2: Your body's supposed to fluctuate.
• 24:16
  Speaker 1: Right.
• 24:16
  Speaker 2: AI can estimate probabilities beautifully. but it cannot determine human trade-offs.
• 24:22
  Speaker 2: Shared decision-making with a human doctor is simply irreplaceable. They
• 24:25
  Speaker 2: help you contextualize the data.
• 24:27
  Speaker 1: So to refine these AI tools without over-medicalizing normal life,
• 24:32
  Speaker 1: we need better ways to test them in the real world, continuously.
• 24:37
  Speaker 1: Which means we have to change how we do clinical trials.
• 24:40
  Speaker 2: The standard trial is too rigid. AI enables what we
• 24:44
  Speaker 2: call adaptive clinical trials.
• 24:46
  Speaker 1: Adaptive trials, meaning they change as they go.
• 24:49
  Speaker 2: Exactly. They dynamically modify the study parameters safely as real-time
• 24:53
  Speaker 2: evidence accumulates. If one treatment arm is clearly working better
• 24:57
  Speaker 2: for a specific genetic group, the algorithm shifts more patients
• 25:00
  Speaker 2: to that arm mid-trial.
• 25:03
  Speaker 1: Oh, that's brilliant. It leads to this concept of a
• 25:06
  Speaker 1: learning healthcare system.
• 25:08
  Speaker 2: Right. Patients receive care, the outcomes are measured, the AI
• 25:12
  Speaker 2: analyzes the patterns, recommendations improve, and the cycle repeats endlessly.
• 25:18
  Speaker 1: It's just like a navigation app on your phone. Like,
• 25:20
  Speaker 1: it reroutes your drive in real time when it detects
• 25:23
  Speaker 1: a traffic jam ahead.
• 25:24
  Speaker 2: That's a great way to visualize it. But I have
• 25:26
  Speaker 2: to issue a strict warning here about real-world data. Observational
• 25:31
  Speaker 2: data is full of confounding factors.
• 25:33
  Speaker 1: Confounding factors. Meaning what?
• 25:36
  Speaker 2: Meaning that searching massive data sets can produce really impressive-looking
• 25:39
  Speaker 2: patterns purely by chance. Or because of hidden variables, like
• 25:44
  Speaker 2: socioeconomic status affecting who gets what drug. Oh, right. Scientific
• 25:49
  Speaker 2: rigor is more important now, not less. We have to
• 25:52
  Speaker 2: ensure we are seeing actual biological causation, not just mathematical correlation.
• 25:57
  Speaker 1: Let's apply this continuous learning and this tension between correlation
• 26:01
  Speaker 1: and causation to two things every single listener thinks about daily,
• 26:05
  Speaker 1: what we eat and how we age.
• 26:07
  Speaker 2: The commercialization of those two fields is massive right now.
• 26:10
  Speaker 1: It really is. AI analyzes molecular data to estimate your
• 26:14
  Speaker 1: biological age, right, like opposed to your chronological age.
• 26:17
  Speaker 2: Yes, using things called epigenetic clocks. They measure changes in
• 26:21
  Speaker 2: how your DNA is expressed over time.
• 26:24
  Speaker 1: And it also looks at the microbiome.
• 26:26
  Speaker 2: The gut microbiome, yes. The trillions of microbes in your
• 26:30
  Speaker 2: digestive system. It influences your immunity, your metabolism, and it
• 26:34
  Speaker 2: changes based on your diet, where you live, what medications
• 26:37
  Speaker 2: you take.
• 26:38
  Speaker 1: So wait. I see all these expensive, commercial, personalized AI
• 26:42
  Speaker 1: diet plans online. They ask for a gut swab and
• 26:46
  Speaker 1: then tell you exactly what to eat. Are they jumping
• 26:48
  Speaker 1: the gun?
• 26:49
  Speaker 2: Absolutely. Okay. They are way ahead of the actual science.
• 26:53
  Speaker 2: Commercial claims always move faster than peer-reviewed evidence.
• 26:56
  Speaker 1: So just because an algorithm finds a pattern doesn't mean
• 26:59
  Speaker 1: it's a cure. Exactly.
• 27:00
  Speaker 2: Exactly. Finding a microbial pattern that correlates with a disease
• 27:04
  Speaker 2: does not prove that eating differently to change your microbiome
• 27:08
  Speaker 2: will cure or prevent that disease.
• 27:10
  Speaker 1: So it's correlation versus causation again.
• 27:12
  Speaker 2: Entirely. Interventions must genuinely improve outcomes in controlled studies before
• 27:18
  Speaker 2: they are validated. Right now, a lot of it is
• 27:20
  Speaker 2: just highly sophisticated guesswork.
• 27:22
  Speaker 1: Which is wild, considering how much people pay for it.
• 27:25
  Speaker 2: It is.
• 27:26
  Speaker 1: Well, this has been an incredibly dense journey. To summarize,
• 27:30
  Speaker 1: the future we're looking at isn't just a single giant
• 27:32
  Speaker 1: AI that knows everything. It's a coordinated system of highly
• 27:36
  Speaker 1: specialized tools, empowering doctors to understand the disease, understand the patient,
• 27:41
  Speaker 1: and pick the best intervention.
• 27:43
  Speaker 2: The goal isn't just hoarding more data. It is making
• 27:46
  Speaker 2: better decisions that improve real human lives.
• 27:49
  Speaker 1: Beautifully said. And for you, the listener, this means moving
• 27:52
  Speaker 1: away from being treated as just a statistical average. We
• 27:56
  Speaker 1: are stepping into an era where your health care is
• 27:58
  Speaker 1: going to be as unique as your fingerprint. But before
• 28:01
  Speaker 1: we wrap up, I want to leave you with a
• 28:03
  Speaker 1: final thought to ponder. We talked a lot about prediction today.
• 28:07
  Speaker 1: If AI and digital twins become so unbelievably advanced that
• 28:12
  Speaker 1: they can predict you will develop a specific disease 20
• 28:15
  Speaker 1: years from now with high certainty, at what point does
• 28:19
  Speaker 1: a mathematical prediction legally or ethically become a pre-existing condition?
• 28:24
  Speaker 1: How will knowing your biological destiny decades in advance change
• 28:28
  Speaker 1: your identity, your life choices, and your fundamental sense of
• 28:32
  Speaker 1: free will today? Something to think about. We'll catch you
• 28:35
  Speaker 1: on the next deep dive.